Viemed Healthcare (VMD) Shareholder's Equity Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Viemed Healthcare | 373.53 Mn | 365.70 Mn | 42.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.62% |
| Dec 31, 2025 | 7.67% |
| Sep 30, 2025 | 6.86% |
| Jun 30, 2025 | 16.87% |
| Mar 31, 2025 | 17.61% |
| Dec 31, 2024 | 17.04% |
| Sep 30, 2024 | 16.52% |
| Jun 30, 2024 | 15.96% |
| Mar 31, 2024 | 16.23% |
| Dec 31, 2023 | 17.30% |
| Sep 30, 2023 | 15.87% |
| Jun 30, 2023 | 12.10% |
| Mar 31, 2023 | 4.16% |
| Dec 31, 2022 | 2.40% |
| Sep 30, 2022 | 5.07% |
| Jun 30, 2022 | 8.07% |
| Mar 31, 2022 | 15.13% |
| Dec 31, 2021 | 16.07% |
| Sep 30, 2021 | 18.85% |
| Jun 30, 2021 | 21.28% |
| Mar 31, 2021 | 70.96% |
| Dec 31, 2020 | 86.94% |
| Sep 30, 2020 | 86.48% |
| Jun 30, 2020 | 96.83% |
| Mar 31, 2020 | 43.98% |
| Dec 31, 2019 | 34.17% |
| Sep 30, 2019 | 32.68% |
| Jun 30, 2019 | 31.42% |
| Mar 31, 2019 | 36.99% |